中文English
ISSN 1001-5256
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
中国抗癌协会肿瘤营养专业委员会,中华医学会肠外肠内营养学分会. 胆道肿瘤患者的营养治疗共识[J]. 临床肝胆病杂志, 2021, 37(9): 2058-2061. DOI: 10.3969/j.issn.1001-5256.2021.09.011
引用本文: 中国抗癌协会肿瘤营养专业委员会,中华医学会肠外肠内营养学分会. 胆道肿瘤患者的营养治疗共识[J]. 临床肝胆病杂志, 2021, 37(9): 2058-2061. DOI: 10.3969/j.issn.1001-5256.2021.09.011
Chinese Society of Nutritional Oncology, Chinese Society for Parenteral and Enteral Nutrition. Expert opinion on nutritional treatment for patients with biliary tract tumors[J]. J Clin Hepatol, 2021, 37(9): 2058-2061. DOI: 10.3969/j.issn.1001-5256.2021.09.011
Citation: Chinese Society of Nutritional Oncology, Chinese Society for Parenteral and Enteral Nutrition. Expert opinion on nutritional treatment for patients with biliary tract tumors[J]. J Clin Hepatol, 2021, 37(9): 2058-2061. DOI: 10.3969/j.issn.1001-5256.2021.09.011

胆道肿瘤患者的营养治疗共识

DOI: 10.3969/j.issn.1001-5256.2021.09.011
基金项目: 

国家重点研发计划项目 2017YFC1309203

详细信息

    通信作者:石汉平,shihp@ccmu.edu.cn

  • 中图分类号: R735.8

Expert opinion on nutritional treatment for patients with biliary tract tumors

Funds: 

National Key Research and Development Program 2017YFC1309203

  • 摘要: 胆道系统恶性肿瘤在世界范围内虽然不算常见,但其发病率逐年上升,且恶性程度较高。我国胆道系统恶性肿瘤的发病率也有逐年上升的趋势。胆管癌患者的预后均很差,因此,胆道系统恶性肿瘤的姑息和支持治疗尤为重要,其主要目的是尽可能地提高生活质量、延长生存时间。肝门部胆管癌患者术后早期进食能够有效减少感染、腹胀和尿潴留等并发症的发生,加快患者术后康复。胆道恶性肿瘤营养治疗途径的选择原则与其他恶性肿瘤基本一致,但也有其特点: (1)胆道手术多限于上消化道,空肠以下肠管受影响较小。(2)对于术前存在营养不良,特别是合并中度以上梗阻性黄疸的患者,建议经口或经鼻空肠置管或者经T形管空肠置管途径肠内营养。(3)对于肝功能储备较差、行较大范围肝切除或严重梗阻性黄疸的患者,应积极行胆道内支架引流或行经皮肝穿刺胆道引流术进行胆道减压,尽快改善肝功能,促进营养物质代谢吸收。(4)经皮肝穿刺胆道引流(PTCD)是临床广泛应用的治疗恶性胆道梗阻的方法。

     

  • [1] HUNDAL R, SHAFFER EA. Gallbladder cancer: Epidemiology and outcome[J]. Clin Epidemiol, 2014, 6: 99-109. DOI: 10.2147/CLEP.S37357.
    [2] GONG XL, QIN SK, LIU XF. Progress of medical treatment for biliary tract cancer[J]. Chin Clin Oncol, 2013, 18(5): 459-467. DOI: 10.3969/j.issn.1009-0460.2013.05.018.

    龚新雷, 秦叔逵, 刘秀峰. 胆系肿瘤的内科治疗进展[J]. 临床肿瘤学杂志, 2013, 18(5): 459-467. DOI: 10.3969/j.issn.1009-0460.2013.05.018.
    [3] LAZCANO-PONCE EC, MIQUEL JF, MUÑOZ N, et al. Epidemiology and molecular pathology of gallbladder cancer[J]. CA Cancer J Clin, 2001, 51(6): 349-364. DOI: 10.3322/canjclin.51.6.349.
    [4] TUO JY, ZHANG M, ZHENG RS, et al. Report of incidence and mortality of gallbladder cancer in China, 2014[J]. Chin J Oncol, 2018, 40(12): 894-899. DOI: 10.3760/cma.j.issn.0253-3766.2018.12.004.

    庹吉妤, 张敏, 郑荣寿, 等. 中国2014年胆囊癌发病与死亡情况分析[J]. 中华肿瘤杂志, 2018, 40(12): 894-899. DOI: 10.3760/cma.j.issn.0253-3766.2018.12.004.
    [5] LEVY AD, MURAKATA LA, ROHRMANN CA Jr. Gallbladder carcinoma: Radiologic-pathologic correlation[J]. Radiographics, 2001, 21(2): 295-314; questionnaire, 549-555. DOI: 10.1148/radiographics.21.2.g01mr16295.
    [6] RAI A, TEWARI M, MOHAPATRA SC, et al. Correlation of nutritional parameters of gallbladder cancer patients[J]. J Surg Oncol, 2006, 93(8): 705-708. DOI: 10.1002/jso.20539.
    [7] GUO J, ZHOU YB, ZHAI ZM, et al. Malnutrition evaluation and postoperative complications in patients with hilar cholangiocarcinoma[J]. Chin J Gen Pract, 2016, 14 (8): 1266-1268. DOI: 10.16766/j.cnki.issn.1674-4152.2016.08.007.

    郭剑, 周永斌, 翟泽民, 等. 肝门部胆管癌患者营养不良评估与术后并发症的相关研究[J]. 中华全科医学, 2016, 14 (8): 1266-1268. DOI: 10.16766/j.cnki.issn.1674-4152.2016.08.007.
    [8] MIYATA T, YAMASHITA YI, HIGASHI T, et al. The prognostic impact of controlling nutritional status (CONUT) in intrahepatic cholangiocarcinoma following curative hepatectomy: A retrospective single institution study[J]. World J Surg, 2018, 42(4): 1085-1091. DOI: 10.1007/s00268-017-4214-1.
    [9] SHIRAKAWA H, KINOSHITA T, GOTOHDA N, et al. Compliance with and effects of preoperative immunonutrition in patients undergoing pancreaticoduodenectomy[J]. J Hepatobiliary Pancreat Sci, 2012, 19(3): 249-58. DOI: 10.1007/s00534-011-0416-3.
    [10] MARIETTE C, de BOTTON ML, PIESSEN G. Surgery inesophageal and gastric cancer patients: What is the role for nutrition support in your daily practice?[J]. Ann Surg Oncol, 2012, 19(7): 2128-2134. DOI: 10.1245/s10434-012-2225-6.
    [11] LIU SH. Effect of perioperative nutritional risk screening and nutritional support on clinical outcome in patients undergoing hepatobiliary surgery[D]. Guangzhou: Southern Medical University, 2016.

    刘升辉. 肝胆手术病人围手术期营养风险筛查及营养支持对临床结局的影响[D]. 广州: 南方医科大学, 2016.
    [12] LILLEMOE HA, ALOIA TA. Enhanced recovery after surgery: Hepatobiliary[J]. Surg Clin North Am, 2018, 98(6): 1251-1264. DOI: 10.1016/j.suc.2018.07.011.
    [13] ARENDS J, BACHMANN P, BARACOS V, et al. ESPEN guidelines on nutrition in cancer patients[J]. Clin Nutr, 2017, 36(1): 11-48. DOI: 10.1016/j.clnu.2016.07.015.
    [14] MANSOUR JC, ALOIA TA, CRANE CH, et al. Hilar cholangiocarcinoma: Expert consensus statement[J]. HPB (Oxford), 2015, 17(8): 691-699. DOI: 10.1111/hpb.12450.
    [15] SUN XM, TANG XF, SUN LY. Therapeutic strategy to malignant biliary obstruction[J/CD]. Electronic J Metabol Nutr Cancer, 2017, 4 (1): 11-15. DOI: 10.16689/j.cnki.cn11-9349/r.2017.01.003.

    孙晓梅, 唐秀芬, 孙凌宇. 恶性胆道梗阻的治疗对策[J/CD]. 肿瘤代谢与营养电子杂志, 2017, 4 (1): 11-15. DOI: 10.16689/j.cnki.cn11-9349/r.2017.01.003.
    [16] ZHAO XH, TANG J, TENG CL, et al. The influence of bile reinfusion on postoperative complications and nutritional status in patients after pancreaticoduodenectomy[J]. J Guangxi Med Univ, 2017, 34 (5): 746-750. DOI: 10.16190/j.cnki.45-1211/r.2017.05.029.

    赵新华, 唐娟, 滕春兰, 等. 胆汁回输对胰十二指肠切除患者术后并发症及营养状态的影响[J]. 广西医科大学学报, 2017, 34 (5): 746-750. DOI: 10.16190/j.cnki.45-1211/r.2017.05.029.
    [17] HESLIN MJ, LATKANY L, LEUNG D, et al. A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy[J]. Ann Surg, 1997, 226(4): 567-577; discussion 577-580. DOI: 10.1097/00000658-199710000-00016.
    [18] WAKAHARA T, SHIRAKI M, MURASE K, et al. Nutritional screening with Subjective Global Assessment predicts hospital stay in patients with digestive diseases[J]. Nutrition, 2007, 23(9): 634-639. DOI: 10.1016/j.nut.2007.06.005.
    [19] GUPTA D, VASHI PG, LAMMERSFELD CA, et al. Role of nutritional status in predicting the length of stay in cancer: A systematic review of the epidemiological literature[J]. Ann Nutr Metab, 2011, 59(2-4): 96-106. DOI: 10.1159/000332914.
    [20] SOMMACAL HM, BERSCH VP, VITOLA SP, et al. Perioperative synbiotics decrease postoperative complications in periampullary neoplasms: A randomized, double-blind clinical trial[J]. Nutr Cancer, 2015, 67(3): 457-462. DOI: 10.1080/01635581.2015.1004734.
    [21] KANAZAWA H, NAGINO M, KAMIYA S, et al. Synbiotics reduce postoperative infectious complications: A randomized controlled trial in biliary cancer patients undergoing hepatectomy[J]. Langenbecks Arch Surg, 2005, 390(2): 104-113. DOI: 10.1007/s00423-004-0536-1.
    [22] KRVGER J, MEFFERT PJ, VOGT LJ, et al. Early parenteral nutrition in patients with biliopancreatic mass lesions, a prospective, randomized intervention trial[J]. PLoS One, 2016, 11(11): e0166513. DOI: 10.1371/journal.pone.0166513.
    [23] JO S, CHOI SH, HEO JS, et al. Missing effect of glutamine supplementation on the surgical outcome after pancreaticoduodenectomy for periampullary tumors: A prospective, randomized, double-blind, controlled clinical trial[J]. World J Surg, 2006, 30(11): 1974-1982; discussion 1983-1984. DOI: 10.1007/s00268-005-0678-5.
    [24] SHI HP, XU HX, LI SY, et al. Five-stepped therapy for malnutrition[J/CD]. Electronic J Metabol Nutr Cancer, 2015, 2(1): 29-33.

    石汉平, 许红霞, 李苏宜, 等. 营养不良的五阶梯治疗[J/CD]. 肿瘤代谢与营养电子杂志, 2015, 2(1): 29-33.
  • 加载中
计量
  • 文章访问数:  45
  • HTML全文浏览量:  14
  • PDF下载量:  27
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-07-29
  • 修回日期:  2021-07-29
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回